Filing Flows › CareDx (CDNA) › Q2 2025
CareDx (CDNA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
CareDx (CDNA) reported revenue of $86.7M for the second quarter 2025 (Q2 2025), -6% from a year earlier and +2% from the quarter before. Operating margin was -12.8%, net loss $8.6M (9.9% of revenue).
CareDx, Q2 2025: revenue $86.7M (-6% year over year), operating margin -12.8%, net loss $8.6M, operating cash flow $9.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $86.7M | +2% | -6% |
| Operating profit | −$11.1M | — | — |
| Net earnings | −$8.6M | — | — |
| Operating cash flow | $9.9M | — | -48% |
| Free cash flow | $8.9M | — | — |
What changed
Revenue was $86.7M in Q2 2025, down 6% year over year and up 2% from the previous quarter. Testing services revenue was the largest line at 72% of revenue. Testing services revenue lost $8.9M year over year (down 13%), 159% of the total change.
Operating costs exceeded revenue by $11.1M, an operating margin of -12.8%. Total costs fell 2% while revenue fell 6%. The fastest-growing cost line was Sales & marketing (+16%). The quarter ended with a net loss of $8.6M, narrower than the previous quarter's $10.4M loss. Non-operating items added $2.4M, -28% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $9.9M (down 48% year over year). Non-cash charges added back $3.7M of depreciation and amortization and $9.4M of share-based compensation. Working capital and other items added $5.3M. Capital expenditures of $1.0M left free cash flow of $8.9M.
Questions
What was CareDx's revenue in the second quarter 2025?
CareDx (CDNA) reported revenue of $86.7M for the second quarter 2025 (Q2 2025), -6% from a year earlier and +2% from the quarter before.
Was CareDx profitable in the second quarter 2025?
Operating loss was $11.1M (-12.8% of revenue) and net loss $8.6M.
Source: CareDx 10-Q on SEC EDGAR.